0.4045
0.61%
-0.0025
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Trevena Inc Borsa (TRVN) Ultime notizie
Will Trevena Continue to Surge Higher? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Wainwright cuts Trevena stock target, maintains Buy rating - Investing.com South Africa
Investing.com South Africa
Wainwright cuts Trevena stock target, maintains Buy rating - Investing.com Canada
Investing.com Canada
Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com - Defense World
Defense World
Trevena Inc. Under Fire: Unregistered Equity Sales Risk Legal Woes and Market Trust - TipRanks.com - TipRanks
TipRanks
Trevena Reports Progress in Pain and Epilepsy Treatment Development, Amid Financial Adjustments - MyChesCo
MyChesCo
Trevena's NDA for Pain Drug Oliceridine Gets FDA Acceptance - Yahoo News Australia
Yahoo News Australia
Industry faces next wave of layoffs: Bolt, Biomarin making cuts - BioWorld Online
BioWorld Online
Trevena Inc expected to post a loss of 47 cents a share - Earnings Preview - XM
XM
Postoperative Pain Therapeutics Service Market [2024-2031] | Mallinckrodt Pharmaceuticals, Trevena, Inc. - Motions Online
Motions Online
Trevena (NASDAQ:TRVN) Research Coverage Started at StockNews.com - Defense World
Defense World
Trevena (NASDAQ:TRVN) Stock Crosses Below 200 Day Moving Average of $0.56 - Defense World
Defense World
Apellis (APLS) Up on Tie-up With Beam for Novel Therapies - Yahoo Movies Canada
Yahoo Movies Canada
Trevena Ramps Up Efforts on TRV045, Turns Attention Away from OLINVYK Amid Challenging Hospital Environment - MyChesCo
MyChesCo
Trevena Inc Unveils Updated Corporate Strategy Presentation - TipRanks.com - TipRanks
TipRanks
Trevena: Q4 Earnings Snapshot - Quartz
Quartz
Trevena faces Nasdaq delisting over share price By Investing.com - Investing.com
Investing.com
CustomerInsights.AI Announces Strategic Advisory Board Members for 2024 - PR Newswire
PR Newswire
Opioid Use Disorder Treatment Market Targets US$ 8.4 Billion by 2033, Fueled by Buprenorphine's 81.4 - PharmiWeb.com
PharmiWeb.com
Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise
GlobeNewswire Inc.
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
GlobeNewswire Inc.
Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting
GlobeNewswire Inc.
Trevena Awarded OLINVYK Agreement with Premier, Inc.
GlobeNewswire Inc.
Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Benzinga
Trevena Appoints Mark Corrigan, M.D. to Board of Directors - citybiz
citybiz
Oliceridine Presents Low Risk for Opioid-Induced Respiratory Depression - Anesthesiology News
Anesthesiology News
Lab Notes: Trevena receives $3M payment; Wayne firm raises $7.2M - The Business Journals
The Business Journals
Jiangsu Nhwa receives China's NMPA approval for Olinvyk - Pharmaceutical Technology
Pharmaceutical Technology
Trevena (TRVN) Initiates Proof-of-Concept for Epilepsy Candidate - Yahoo Movies Canada
Yahoo Movies Canada
Rich Insights into the Opioid Dependence Clinical Trial Analysis Featuring 25+ Companies and Therapies | DelveInsight - GlobeNewswire
GlobeNewswire
Keaton Trevena Obituary (2022) - Tampa, FL - Cremations of Greater Tampa Bay, Inc. - Tampa - Legacy.com
Legacy.com
Trevena lays off 25% of its staff in a low-key restructure - FiercePharma
FiercePharma
Rockwell Medical Appoints Mark Strobeck, Ph.D., as CEO - citybiz
citybiz
Lab Notes: AmerisourceBergen teams with UK tech firm; Chimeron Bio relocates to Center City - The Business Journals
The Business Journals
Trevena Inc. (NASDAQ: TRVN) Reports Q3 2021 Net Loss of $13.9 Million It Advances OLINVYK To Commercial Launch - BP Journal
BP Journal
Postoperative Pain Market to Rising Steadily at a 7.93% CAGR Owing to Growing Number of Surgeries, During the ... - PR Newswire
PR Newswire
Geron (GERN) Soars on Imetelstat Data for Myelofibrosis - Yahoo Finance
Yahoo Finance
Trevena's OLINVYK Provides Compelling Growth Profile (NASDAQ:TRVN) - Seeking Alpha
Seeking Alpha
Vanessa Hudgens Teams Up with BFF Oliver Trevena to Launch Caliwater!: Photo 4547007 | Oliver Trevena, Vanessa ... - Just Jared
Just Jared
Vanessa Hudgens Is Launching a New Beverage Company With Oliver Trevena - Just Jared Jr.
Just Jared Jr.
Trevena: Reaffirming A Buy On OLINVYK DEA Scheduling (NASDAQ:TRVN) - Seeking Alpha
Seeking Alpha
Navy Yard returns to its roots while some Philly start-ups depart for the suburbs - The Philadelphia Inquirer
The Philadelphia Inquirer
OLINVYK (oliceridine) for the Treatment of Acute Pain - Clinical Trials Arena
Clinical Trials Arena
Trevena soars as it gains FDA approval for Olinvyk - The Pharma Letter
The Pharma Letter
Trevena (TRVN) Just Days Away From FDA Decision - RTTNews
RTTNews
Trevena Inc.'s (NASDAQ:TRVN) Chinese Partner Receives Oluceridine Approval As The company Announces ... - BP Journal
BP Journal
Daily Earnings Surprises - Nasdaq
Nasdaq
3 Biotech Stocks Under $2 With Massive Upside Potential - Yahoo Finance
Yahoo Finance
Trevena resubmits new drug application to USFDA for Oliceridine - Clinical Trials Arena
Clinical Trials Arena
Will Trevena Continue to Surge Higher? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Capitalizzazione:
|
Volume (24 ore):